rs1002061 - GTF3AP5 - AGMO

Magnitude 2.2 · 1 study on file

Reported associations

  • Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes - Unknown journal (n.d.) · Unknown authors · PubMed 29358691

    ABSTRACT: The reanalysis of existing GWAS data represents a powerful and cost-effective opportunity to gain insights into the genetics of complex diseases. By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662075, associated with a twofold increased risk for T2D in males. rs146662075 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells. Beyond providing insi


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Type 2 diabetes genetic risk assessment Moderate

    rs1002061 A allele associated with 7.9% increased type 2 diabetes odds based on GWAS of 168,420 individuals